{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=TIV+%28Fluzone%29+Influenza+Vaccination&page=3",
    "query": {
      "intervention": "TIV (Fluzone) Influenza Vaccination",
      "page": 3
    },
    "page_size": 10
  },
  "pagination": {
    "page": 3,
    "page_size": 10,
    "total_count": 350,
    "total_pages": 35,
    "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=TIV+%28Fluzone%29+Influenza+Vaccination&page=4&page_size=10",
    "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=TIV+%28Fluzone%29+Influenza+Vaccination&page=2&page_size=10"
  },
  "source": "remote",
  "last_synced_at": "2026-10-09T21:11:31.119Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT05832307",
      "title": "The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program",
      "overall_status": "RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Influenza"
      ],
      "interventions": [
        {
          "name": "Existing Influenza Vaccination Practices",
          "type": "OTHER"
        },
        {
          "name": "Standardized inpatient influenza vaccination program",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "OTHER"
      ],
      "sponsor": "University of Colorado, Denver",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "6 Months",
        "maximum_age": "99 Years",
        "sex": "ALL",
        "summary": "6 Months to 99 Years"
      },
      "enrollment_count": 22000,
      "start_date": "2024-10-31",
      "completion_date": "2027-07-31",
      "has_results": false,
      "last_update_posted_date": "2026-04-08",
      "last_synced_at": "2026-10-09T21:11:31.119Z",
      "location_count": 2,
      "location_summary": "Chicago, Illinois • Seattle, Washington",
      "locations": [
        {
          "city": "Chicago",
          "state": "Illinois"
        },
        {
          "city": "Seattle",
          "state": "Washington"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05832307"
    },
    {
      "nct_id": "NCT03442582",
      "title": "Afluria Pregnancy Registry",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Influenza, Human",
        "Pregnancy",
        "Birth Defect"
      ],
      "interventions": [
        {
          "name": "Afluria Influenza Vaccine",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "Seqirus",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": null,
        "sex": "FEMALE",
        "summary": "Female only"
      },
      "enrollment_count": 490,
      "start_date": "2017-09-08",
      "completion_date": "2021-09-14",
      "has_results": false,
      "last_update_posted_date": "2022-02-09",
      "last_synced_at": "2026-10-09T21:11:31.119Z",
      "location_count": 1,
      "location_summary": "Wilmington, North Carolina",
      "locations": [
        {
          "city": "Wilmington",
          "state": "North Carolina"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03442582"
    },
    {
      "nct_id": "NCT01388439",
      "title": "Pharmacokinetics of Oseltamivir in Newborns and Infants",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Prematurity of Fetus"
      ],
      "interventions": [
        {
          "name": "Oseltamivir",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "St. Louis Children's Hospital",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": "6 Months",
        "sex": "ALL",
        "summary": "Up to 6 Months"
      },
      "enrollment_count": 19,
      "start_date": "2011-01",
      "completion_date": "2011-01",
      "has_results": false,
      "last_update_posted_date": "2011-07-06",
      "last_synced_at": "2026-10-09T21:11:31.119Z",
      "location_count": 1,
      "location_summary": "St Louis, Missouri",
      "locations": [
        {
          "city": "St Louis",
          "state": "Missouri"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01388439"
    },
    {
      "nct_id": "NCT01467934",
      "title": "FeverText: Assessing Fever Rates After Vaccination During the 2011-12 Influenza Season Using Text Messaging",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Fever"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "Columbia University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "6 Months",
        "maximum_age": "23 Months",
        "sex": "ALL",
        "summary": "6 Months to 23 Months"
      },
      "enrollment_count": 530,
      "start_date": "2011-11",
      "completion_date": "2012-06",
      "has_results": true,
      "last_update_posted_date": "2014-07-21",
      "last_synced_at": "2026-10-09T21:11:31.119Z",
      "location_count": 2,
      "location_summary": "Atlanta, Georgia • New York, New York",
      "locations": [
        {
          "city": "Atlanta",
          "state": "Georgia"
        },
        {
          "city": "New York",
          "state": "New York"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01467934"
    },
    {
      "nct_id": "NCT00380679",
      "title": "Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department",
      "overall_status": "UNKNOWN",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "High Risk for Serious Influenza",
        "High Risk for Pneumonia"
      ],
      "interventions": [
        {
          "name": "Influenza vaccination",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Pneumococcal polysaccharide vaccination",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "Louisiana State University Health Sciences Center in New Orleans",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": null,
      "start_date": "2005-12",
      "completion_date": "2006-03",
      "has_results": false,
      "last_update_posted_date": "2006-09-26",
      "last_synced_at": "2026-10-09T21:11:31.119Z",
      "location_count": 2,
      "location_summary": "Baton Rouge, Louisiana",
      "locations": [
        {
          "city": "Baton Rouge",
          "state": "Louisiana"
        },
        {
          "city": "Baton Rouge",
          "state": "Louisiana"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00380679"
    },
    {
      "nct_id": "NCT05052190",
      "title": "Patient Portal Flu Vaccine Reminders_RCT 4",
      "overall_status": "TERMINATED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Influenza",
        "Respiratory Tract Infections"
      ],
      "interventions": [
        {
          "name": "Text Message R/R with Direct Appointment Schedule Link",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Text Message R/R without Direct Appointment Schedule Link",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Text Pre-Appointment Reminder",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Portal Message R/R with Direct Appointment Schedule Link",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Portal Message R/R without Direct Appointment Schedule Link",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Portal Pre-Appointment Reminder",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "University of California, Los Angeles",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "6 Months",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "6 Months and older"
      },
      "enrollment_count": 239567,
      "start_date": "2021-10-14",
      "completion_date": "2022-04-01",
      "has_results": true,
      "last_update_posted_date": "2025-04-11",
      "last_synced_at": "2026-10-09T21:11:31.119Z",
      "location_count": 1,
      "location_summary": "Los Angeles, California",
      "locations": [
        {
          "city": "Los Angeles",
          "state": "California"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05052190"
    },
    {
      "nct_id": "NCT03982069",
      "title": "Immunologic Response to FluMist vs. Flucelvax",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE4"
      ],
      "conditions": [
        "Influenza, Human",
        "Immune Response"
      ],
      "interventions": [
        {
          "name": "FluMist live attenuated influenza vaccine",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Flucelvax inactivated influenza vaccine",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "Richard Zimmerman MD",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "4 Years",
        "maximum_age": "21 Years",
        "sex": "ALL",
        "summary": "4 Years to 21 Years"
      },
      "enrollment_count": 465,
      "start_date": "2019-09-20",
      "completion_date": "2020-12-09",
      "has_results": true,
      "last_update_posted_date": "2021-10-14",
      "last_synced_at": "2026-10-09T21:11:31.119Z",
      "location_count": 2,
      "location_summary": "Pittsburgh, Pennsylvania",
      "locations": [
        {
          "city": "Pittsburgh",
          "state": "Pennsylvania"
        },
        {
          "city": "Pittsburgh",
          "state": "Pennsylvania"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03982069"
    },
    {
      "nct_id": "NCT05028361",
      "title": "Simultaneous mRNA COVID-19 and IIV4 Vaccination Study",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE4"
      ],
      "conditions": [
        "Quality of Life",
        "Injection Site Reaction",
        "Adverse Drug Event",
        "Systemic Reaction"
      ],
      "interventions": [
        {
          "name": "mRNA COVID-19",
          "type": "BIOLOGICAL"
        },
        {
          "name": "IIV4",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Placebo (saline)",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL",
        "OTHER"
      ],
      "sponsor": "Duke University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "5 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "5 Years and older"
      },
      "enrollment_count": 348,
      "start_date": "2021-10-04",
      "completion_date": "2023-06-15",
      "has_results": true,
      "last_update_posted_date": "2024-03-19",
      "last_synced_at": "2026-10-09T21:11:31.119Z",
      "location_count": 3,
      "location_summary": "Baltimore, Maryland • Durham, North Carolina • Cincinnati, Ohio",
      "locations": [
        {
          "city": "Baltimore",
          "state": "Maryland"
        },
        {
          "city": "Durham",
          "state": "North Carolina"
        },
        {
          "city": "Cincinnati",
          "state": "Ohio"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05028361"
    },
    {
      "nct_id": "NCT00569894",
      "title": "A Post Marking Study to Evaluate the Safety of FluMist in Children",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Healthy"
      ],
      "interventions": [
        {
          "name": "FLuMist",
          "type": "BIOLOGICAL"
        },
        {
          "name": "TIV (Injection)",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Unvaccinated Control",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL",
        "OTHER"
      ],
      "sponsor": "MedImmune LLC",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "24 Months",
        "maximum_age": "59 Months",
        "sex": "ALL",
        "summary": "24 Months to 59 Months"
      },
      "enrollment_count": 29296,
      "start_date": "2007-10",
      "completion_date": "2011-06",
      "has_results": false,
      "last_update_posted_date": "2012-03-08",
      "last_synced_at": "2026-10-09T21:11:31.119Z",
      "location_count": 1,
      "location_summary": "Oakland, California",
      "locations": [
        {
          "city": "Oakland",
          "state": "California"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00569894"
    },
    {
      "nct_id": "NCT00812019",
      "title": "Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "Influenza"
      ],
      "interventions": [
        {
          "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_0%MF59",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_25%MF59",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_50%MF59",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_100%MF59",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_0%MF59",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_25%MF59",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_50%MF59",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_100%MF59",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_0%MF59",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_25%MF59",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_50%MF59",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_100%MF59",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "Seqirus",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "40 Years",
        "sex": "ALL",
        "summary": "18 Years to 40 Years"
      },
      "enrollment_count": 753,
      "start_date": "2008-11",
      "completion_date": "2010-11",
      "has_results": false,
      "last_update_posted_date": "2020-08-24",
      "last_synced_at": "2026-10-09T21:11:31.119Z",
      "location_count": 1,
      "location_summary": "Houston, Texas",
      "locations": [
        {
          "city": "Houston",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00812019"
    }
  ]
}